Citation: | WANG Qi, YANG Xingzi, ZHANG Wei, YANG Zhijun, PAN Zhongmian, LI li. Preparing Suspension Array Diagnostic Kit of Matrix Metallo Proteases 9,Heparanase and Cathepsin L and Clinical Validating[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 877-882. DOI: 10.3971/j.issn.1000-8578.2013.09.014 |
[1] |
Shaaban A,Rezvani M.Ovarian cancer:detection and radiologic staging[J].Clin Obstet Gynecol,2009,52(1):73-93.
|
[2] |
Shield K,Ackland ML,Ahmed N, et al. Multicellular spheroids in ovarian cancer metastases:biology and pathology[J].Gynecol Oncol,2009,113(1):143-8.
|
[3] |
Nolan JP,Sklar LA.Suspension array technology:evolution of the flat-array paradigm[J].Trends Biotechnol,2002,20(1):9-12.
|
[4] |
de Jager W,Prakken BJ,Bijlsma JW, et al. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies[J].J Immunol Methods,2005,300(1-2):124-35.
|
[5] |
Chen YS.The clinical utility of rumor biomarkers[J].Zhonghua Jian Yan Yi Xue Za Zhi,2000,23(1):52-5.[陈允硕.肿瘤标志物的临床应用价值[J].中华检验医学杂志,2000,23(1):52-5.]
|
[6] |
Kayaba H.Tumor markers:essential diagnostic tools for radiologists[J].Nihon Igaku Hoshasen Gakkai Zasshi,2003,63(4):133-9.
|
[7] |
Kong XT.Application and evaluation of tumor biomarkers[J].Shi Yong Zhong Liu Za Zhi,2002,17(5):289-92.[孔宪涛.肿瘤标志物应用进展与评价[J].实用肿瘤杂志,2002,17(5):289-92.]
|
[8] |
Alley WR Jr,Madera M,Mechref Y, et al. Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans:a potential methodology for cancer-biomarker discovery[J].Anal Chem,2010,82(12):5095-106.
|
[9] |
Zhang A,Meng L,Wang Q, et al. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2[J].Oncol Rep,2006,15(4):831-6.
|
[10] |
Sakata K,Shigemasa K,Nagai N, et al. Expression of matrix metalloproteinases (MMP-2,MMP-9,MT1-MMP) and their inhibitors (TIMP-1,TIMP-2) in common epithelial tumors of the ovary[J].Int J Oncol,2000,17(4):673-81.
|
[11] |
Hu XX,Li L,LI DR, et al. Inhibitory effects of antisense MMP-9 oligodeoxy nucleotides on invasiveness and adherence of ovarian cancer cells[J].Zhonghua Zhong Liu Za Zhi,2006,28(9):662-5.[胡晓霞,李力,黎丹戎,等.基质金属蛋白酶-9反义寡核苷酸对卵巢癌细胞侵袭黏附能力的影响[J].中华肿瘤杂志,2006,28(9):662-5.]
|
[12] |
Karihtala P,Menp J,Turpeenniemi-Hujanen T, et al. Front-line bevacizumab in serous epithelial ovarian cancer:biomarker analysis of the FINAVAST trial[J].Anticancer Res,2010,30(3):1001-6.
|
[13] |
Krueger S,Kellner U,Buehling F, et al. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line:effects on the invasive phenotype[J].Cancer Gene Ther,2001,8(7):522-8.
|
[14] |
Levicar N,Dewey RA,Daley E, et al. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis[J].Cancer Gene Ther,2003,10(2):141-51.
|
[15] |
Shinyo Y,Kodama J,Hongo A, et al. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer[J].Ann Oncol,2003,14(10):1505-10.
|
[16] |
Mao J,Xin XY,Liu Y, et al. Correlation of expression of heparanase and uPA to invasion of ovarian cancer[J].Xian Dai Zhong Liu Yi Xue,2006,14(3):329-31.[毛敬,辛晓燕,刘玉,等.卵巢癌uPA及HPA的表达与肿瘤转移的相关性研究[J].现代肿瘤医学,2006,14(3):329-31.]
|
[17] |
Epelman M,Chikwava KR,Chauvin N, et al. Imaging of pediatric ovarian neoplasms[J].Pediatr Radiol,2011,41(9):1085-99.
|